Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001279569-16-002975
Filing Date
2016-03-18
Accepted
2016-03-18 11:13:56
Documents
4
Period of Report
2015-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K/A v434613_10ka.htm 10-K/A 247494
2 EXHIBIT 31.1 v434613_ex31-1.htm EX-31.1 7659
3 EXHIBIT 31.2 v434613_ex31-2.htm EX-31.2 7726
4 EXHIBIT 32.1 v434613_ex32-1.htm EX-32.1 6325
  Complete submission text file 0001279569-16-002975.txt   270165
Mailing Address 828 RICHMOND STREET WEST TORONTO A6 M6J 1C9
Business Address 828 RICHMOND STREET WEST TORONTO A6 M6J 1C9 416-703-2449
Cynapsus Therapeutics Inc. (Filer) CIK: 0001532079 (see all company filings)

EIN.: 981226819 | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-37426 | Film No.: 161515141
SIC: 2834 Pharmaceutical Preparations